The role of Gal-3 as a mediator of lung fibrosis has long been studied since the discovery that its levels are elevated in alveolar macrophages following lung injury (Kasper & Hughes, 1996;Nishiet al., 2007). This evidence concerns the gene LGALS3 and pulmonary fibrosis.